Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Limited Isoniazid TB Preventive Therapy in HIV-infected Adults
NCT00164281Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Nov 2004
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Tuberculosis (TB) comparing Continuous isoniazid with Limited isoniazid (6 months) + placebo (2 arms). Primary endpoint: Number of Participants With Incident Tuberculosis at 36 months. Started Nov 2004; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00164281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164281.